{"id":"https://openalex.org/W2169717006","doi":"https://doi.org/10.2337/diacare.25.2.303","title":"A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients","display_name":"A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients","alternate_titles":[],"publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W2169717006","doi":"https://doi.org/10.2337/diacare.25.2.303","mag":"2169717006","pmid":"https://pubmed.ncbi.nlm.nih.gov/11815500"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.25.2.303","doi":"https://doi.org/10.2337/diacare.25.2.303","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.25.2.303","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2169717006"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019040891","display_name":"Mark Lamotte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Lamotte","raw_affiliation_strings":["Health Economics and Disease Management, Meise, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Disease Management, Meise, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007482776","display_name":"Lieven Annemans","orcid":"https://orcid.org/0000-0001-8305-7210","observed_orcids":["https://orcid.org/0000-0001-8305-7210"]},"institutions":[{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lieven Annemans","raw_affiliation_strings":["Health Economics and Disease Management, Meise, Belgium","University of Ghent, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Disease Management, Meise, Belgium","institution_ids":[]},{"raw_affiliation_string":"University of Ghent, Ghent, Belgium","institution_ids":["https://openalex.org/I32597200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110275143","display_name":"Aurelia Lefever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091461","display_name":"Roche (Belgium)","ror":"https://ror.org/00e65d634","country_code":"BE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210091461"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aurelia Lefever","raw_affiliation_strings":["Roche Pharmaceuticals, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Brussels, Belgium","institution_ids":["https://openalex.org/I4210091461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021055263","display_name":"Myriam Nechelput","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091461","display_name":"Roche (Belgium)","ror":"https://ror.org/00e65d634","country_code":"BE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210091461"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Myriam Nechelput","raw_affiliation_strings":["Roche Pharmaceuticals, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Brussels, Belgium","institution_ids":["https://openalex.org/I4210091461"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020733719","display_name":"Johan A. Masure","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091461","display_name":"Roche (Belgium)","ror":"https://ror.org/00e65d634","country_code":"BE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210091461"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johan Masure","raw_affiliation_strings":["Roche Pharmaceuticals, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceuticals, Brussels, Belgium","institution_ids":["https://openalex.org/I4210091461"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7362,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.94883781,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"25","issue":"2","first_page":"303","last_page":"308"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.016300000250339508,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":1.0},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9190000295639038},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9440000057220459},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9190000295639038},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.7239999771118164},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.7770000100135803},{"id":"https://openalex.org/keywords/macrovascular-complications","display_name":"macrovascular complications","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9259999990463257},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.921999990940094},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8309999704360962},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.9150000214576721}],"concepts":[{"id":"https://openalex.org/C2780780548","wikidata":"https://www.wikidata.org/wiki/Q424163","display_name":"Orlistat","level":4,"score":0.9729576706886292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9462548494338989},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6245026588439941},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5934795141220093},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5651749968528748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5519053339958191},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5500100255012512},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4533386528491974},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3209034204483032},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.25607895851135254}],"mesh":[{"descriptor_ui":"D000077403","descriptor_name":"Orlistat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013995","descriptor_name":"Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2337/diacare.25.2.303","doi":"https://doi.org/10.2337/diacare.25.2.303","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.25.2.303","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:11815500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11815500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:archive.ugent.be:165892","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1854/LU-165892","pdf_url":null,"source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 0149-5992","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W1965253461","https://openalex.org/W1970556989","https://openalex.org/W1970652218","https://openalex.org/W1980329518","https://openalex.org/W1987489990","https://openalex.org/W1987974958","https://openalex.org/W1997962556","https://openalex.org/W2009224225","https://openalex.org/W2013271332","https://openalex.org/W2033274080","https://openalex.org/W2037730673","https://openalex.org/W2044052409","https://openalex.org/W2048083913","https://openalex.org/W2062206094","https://openalex.org/W2064100104","https://openalex.org/W2068407303","https://openalex.org/W2082214051","https://openalex.org/W2091630536","https://openalex.org/W2116732628","https://openalex.org/W2118387463","https://openalex.org/W2123946565","https://openalex.org/W2143152039","https://openalex.org/W2164654252","https://openalex.org/W2172124430","https://openalex.org/W2188846692","https://openalex.org/W2337454357","https://openalex.org/W2395957606","https://openalex.org/W2417004996","https://openalex.org/W2599408064","https://openalex.org/W3198570063","https://openalex.org/W4241113672"],"related_works":["https://openalex.org/W2016354863","https://openalex.org/W1982184733","https://openalex.org/W1974142657","https://openalex.org/W2509590045","https://openalex.org/W2567704391","https://openalex.org/W2060268563","https://openalex.org/W1973973651","https://openalex.org/W2048083913","https://openalex.org/W1991138114"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Obesity":[1],"is":[2,186,199],"a":[3,80,91,96],"common":[4],"condition":[5],"in":[6,33,201,211],"type":[7,35,62,206],"2":[8,36,63,207],"diabetic":[9,37,64,166,177,208],"patients.":[10,38],"Treating":[11],"obesity":[12],"may":[13],"enhance":[14],"hypoglycemic":[15],"treatment":[16],"and":[17,25,55,86,89,124,133,135,170,172],"contribute":[18],"to":[19,45,77,107,190],"the":[20,47,56,83,109,113,129,151,202,214],"reduction":[21],"of":[22,41,51,59,115,138,153,204,216,224,230],"long-term":[23,48],"microvascular":[24],"macrovascular":[26,136],"complications.":[27],"Orlistat":[28],"reduces":[29],"cardiovascular":[30],"risk":[31,141,154,181],"factors":[32,142],"obese":[34,61,165,176,205],"The":[39,183],"objectives":[40],"this":[42,52],"study":[43],"were":[44,147],"estimate":[46],"clinical":[49,110],"consequences":[50],"weight":[53,116],"loss":[54,117],"resulting":[57],"cost-effectiveness":[58],"treating":[60],"patients":[65,167,178],"with":[66,88,118,168,213],"orlistat.":[67],"RESEARCH":[68],"DESIGN":[69],"AND":[70],"METHODS:":[71],"A":[72,102],"Markov":[73],"model":[74],"was":[75,105,126,143],"developed":[76],"predict,":[78],"over":[79],"10-year":[81],"period,":[82],"complication":[84],"rates":[85],"mortality":[87,132],"without":[90,179],"2-year":[92],"orlistat":[93,119,198,225],"treatment,":[94],"assuming":[95],"5-year":[97],"catch-up":[98],"period":[99],"after":[100],"treatment.":[101],"stepwise":[103],"approach":[104],"used":[106],"obtain":[108],"data.":[111],"First,":[112],"impact":[114,130],"on":[120,131,150,221],"HbA(1c),":[121],"blood":[122],"pressure,":[123],"cholesterol":[125],"assessed;":[127],"then,":[128],"micro-":[134],"complications":[137],"decreasing":[139],"these":[140],"applied.":[144],"Four":[145],"subgroups":[146],"studied":[148],"based":[149],"presence":[152,215],"factors.":[155,182],"RESULTS:":[156],"Cost-effectiveness":[157],"varies":[158],"between":[159],"3,462":[160],"Euro/life-year":[161],"gained":[162],"(LYG)":[163],"for":[164,175,232],"hypertension":[169],"hypercholesterolemia":[171,217],"19,986":[173],"Euro/LYG":[174],"other":[180],"latter":[184],"result":[185],"not":[187],"robust":[188],"according":[189],"sensitivity":[191],"analyses.":[192],"CONCLUSIONS:":[193],"Our":[194],"results":[195],"suggest":[196],"that":[197],"cost-effective":[200],"management":[203],"patients,":[209],"especially":[210],"those":[212],"and/or":[218],"hypertension.":[219],"Evidence":[220],"longer-term":[222],"benefits":[223],"(>2":[226],"years)":[227],"will":[228],"be":[229],"importance":[231],"future":[233],"decision-making.":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2169717006","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
